Related Experiment Video
Updated: Jan 16, 2026

05:50
Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles
Published on: June 2, 2023
1.8K
What's new in osteoarthritis?
1Menzies Institute for Medical Research, University of Tasmania, Private Bag 23, Hobart, Tasmania, Australia, 7000.
Best Practice & Research. Clinical Rheumatology
|October 2, 2025
Summary
Osteoarthritis (OA) is a growing public health concern. While imaging advances improve understanding of OA pathogenesis, targeted therapies show mixed results, highlighting an urgent need for new treatment options.
Area of Science:
- Orthopedics and Musculoskeletal Diseases
- Rheumatology
- Medical Imaging
Background:
- Osteoarthritis (OA) represents a significant and escalating global health challenge.
- Recent advancements in medical imaging have substantially improved the understanding of OA pathogenesis.
- Both systemic and local factors contribute to OA, with some modifiable factors offering therapeutic targets for precision medicine.
Purpose of the Study:
- To review the current understanding of osteoarthritis pathogenesis.
- To evaluate the efficacy of recent therapeutic strategies, particularly those targeting specific patient subgroups identified by imaging.
- To identify the unmet needs in osteoarthritis treatment.
Main Methods:
- Literature review focusing on recent advances in OA pathogenesis and imaging.
- Analysis of completed clinical trials, including those stratifying patients based on imaging features.
- Synthesis of findings from basic science, human observational studies, and interventional trials.
Main Results:
- Imaging advances have enhanced comprehension of OA's underlying mechanisms.
- Clinical trials targeting subgroups of OA patients based on imaging have yielded inconsistent outcomes.
- Many interventional studies failed to replicate promising results from preclinical and observational research, with most trials reporting negative findings.
Conclusions:
- Despite progress in understanding OA pathogenesis, current therapeutic options remain limited.
- The heterogeneity of OA necessitates further research into personalized treatment approaches.
- There is a critical and urgent requirement for the development of novel and more effective therapies for osteoarthritis management.
Related Concept Videos
Osteoclasts in Bone Remodeling
3.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.9K
Development of the Limb Synovial Joints
2.2K
Joints form during embryonic development in conjunction with the formation and growth of the associated bones. The embryonic tissue that gives rise to all bones, cartilage, and connective tissues of the body is called mesenchyme.
The mesenchymal stem cells differentiate into chondrocytes that form the hyaline cartilage, and later the cartilaginous model of the bone. This model further transforms into a bone. This process is known as endochondral ossification.
During development, the limbs...
The mesenchymal stem cells differentiate into chondrocytes that form the hyaline cartilage, and later the cartilaginous model of the bone. This model further transforms into a bone. This process is known as endochondral ossification.
During development, the limbs...
2.2K

